We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIq-ai Ltd Regulatory News (IQAI)

Share Price Information for Iq-ai Ltd (IQAI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.55
Bid: 1.40
Ask: 1.70
Change: -0.05 (-3.13%)
Spread: 0.30 (21.429%)
Open: 1.60
High: 1.60
Low: 1.55
Prev. Close: 1.60
IQAI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Proposed sale of the Gifts Division

21 Feb 2012 07:59

RNS Number : 7921X
Flying Brands Limited
21 February 2012
 



21 February 2012

Flying Brands Limited (the "Company")

 

Proposed sale of the Gifts Division

 

The Board is pleased to announce that terms have been agreed, subject to shareholder approval, to dispose of the business and assets of the Gifts Division to Interflora British Unit ("Interflora") (the "Disposal") for a gross consideration of £2.4 million, to be satisfied in cash on completion.

 

Following the sale of the properties at Retreat Farm and Meadow Springs in December 2011, the Disposal is a continuation of the Board's strategy to enhance shareholder value. The sale of the Gifts Division will effect the Company's full exit from the direct-to-consumer sale of gifts, including cut flowers and houseplants. Following the Disposal, the focus of the continuing group will be on the Gardening Direct and Garden Bird Supplies businesses. The Company intends to use the proceeds for general working capital purposes.

 

The Gifts Division comprises the Flying Flowers and Flowers Direct businesses along with a small number of retail outlets trading under the Drake Algar brand. Through these businesses, the Gifts Division offers flowers, bouquets and related gifts to customers across the UK. For the year ending 31 December 2010, the Gifts Division generated an operating loss of £0.8 million, and for the six months ending 1 July 2011, an operating loss of £0.8 million. The book value of the assets subject of the Disposal was £3.2 million at 1 July 2011.

 

The Disposal is a Class 1 transaction and is therefore subject to shareholder approval under the Listing Rules. The Company has also been made aware that Interflora is intending to notify the Office of Fair Trading with respect to the acquisition of the Gifts Division for clearance under the Enterprise Act 2002. Both the Company and Interflora have the right, but not the obligation, to terminate the Disposal if the Office of Fair Trading refers the transaction to the UK Competition Commission. A circular containing details of the Disposal and a notice of extraordinary general meeting will be sent to shareholders in due course.

 

Pursuant to the Disposal, the Company's normal timetable for the preliminary announcement of full year results in early March has now changed. Currently it is expected that the full year results will be announced in late April. A further announcement on the timing of the full year results will be made in due course.

 

For further information, please contact:

 

Flying Brands Limited 01245 228 300

Stephen Cook, Chief Executive

Stuart Dootson, Finance Director

 

Smithfield Consultants 020 7360 4900

John Kiely

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBKDDPOBKKFBB
Date   Source Headline
29th Apr 20243:26 pmRNSPublication of Annual Report
5th Mar 20247:00 amRNSGrant of Options
1st Mar 20248:22 amRNSHolding(s) in Company
1st Mar 20248:20 amRNSHolding(s) in Company
26th Feb 20247:00 amRNSResult of Broker Option and Total Voting Rights
22nd Feb 20247:00 amRNSPlacing and Broker Option
9th Feb 202412:49 pmRNSFDA Application Update
2nd Feb 20248:39 amRNSIB awarded a $100,000 grant
22nd Jan 202410:05 amRNSHolding(s) in Company
15th Jan 20247:01 amRNSDirector Dealings and Conversion of CLNs
15th Jan 20247:00 amRNSHolding(s) in Company
10th Jan 20247:00 amRNSIB Launching an Expanded Access Program for GaM
19th Dec 20232:29 pmRNSImaging Biometrics granted FDA “Fast-Track”
5th Dec 202310:58 amRNSIQ-AI Announces Positive Interim Phase 1 Results
20th Nov 20231:42 pmRNSHolding(s) in Company
9th Nov 202311:38 amRNSDirector Dealing and Conversion of CLNs
8th Nov 202310:59 amRNSApplication for Pediatric Rare Disease Designation
6th Nov 20231:02 pmRNSHolding(s) in Company
18th Oct 20232:29 pmRNSUpdate Regarding Imaging Biometrics LLC
13th Oct 20238:55 amRNSIB Letter to Shareholders
9th Oct 20237:00 amRNSOrphan Drug Status to GaM and Total Voting Rights
3rd Oct 202311:30 amRNSHolding(s) in Company
19th Sep 20232:32 pmRNSIQ-AI shares cease trading on the OTCQB
8th Sep 20237:00 amRNSReduced Gadolinium Approach Validated'
18th Aug 202312:06 pmRNSUpdate on Collaboration Agreement with Mayo Clinic
18th Aug 202311:20 amRNSIB & GE HealthCare Enter into Commercial Agreement
17th Aug 20237:00 amRNSHalf-year Report
19th Jul 20237:00 amRNSImaging Biometrics Installs IB Nimble™ For MCW
13th Jul 20237:00 amRNSOrphan Drug Designation for GaM in Pediatric GBM
27th Jun 20237:00 amRNSStudies Show GaM Inhibits Pediatric Tumor Growth
23rd May 202311:02 amRNSResult of AGM
23rd May 20237:00 amRNSAGM Statement
3rd May 20234:14 pmRNSNotice of AGM
26th Apr 20237:00 amRNSFinal Results
28th Feb 20233:52 pmRNSOrphan Drug Designation Status
13th Jan 20232:05 pmRNSSecond Price Monitoring Extn
13th Jan 20232:00 pmRNSPrice Monitoring Extension
13th Jan 202311:05 amRNSSecond Price Monitoring Extn
13th Jan 202311:00 amRNSPrice Monitoring Extension
10th Jan 20237:00 amRNSLetter to Shareholders
2nd Dec 202211:11 amRNSHolding in Company
25th Oct 202211:00 amRNSPrice Monitoring Extension
30th Sep 20227:00 amRNSLetter to Shareholders
26th Sep 20227:00 amRNSIssue of Warrants to Employees
16th Aug 20224:40 pmRNSSecond Price Monitoring Extn
16th Aug 20224:35 pmRNSPrice Monitoring Extension
16th Aug 20229:28 amRNSHalf-year Report
3rd Aug 20221:01 pmRNSTR1 - Notification of Major Holdings
11th Jul 20227:00 amRNSImaging Biometrics Announces Channel Partnership
31st May 202211:05 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.